Item 9 Labs Corp. Launches Reg A+ Public Offering & Keep Cannabis Local Campaign


Ryan Allway

March 9th, 2022

News, Top News


Investors Now Have a Chance to Invest in the First Vertically Integrated U.S. Cannabis Franchise

 

PHOENIXMarch 9, 2022 /PRNewswire/ — Item 9 Labs Corp. (OTCQX: INLB)–a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products–announced today the launch of its global, streamlined Regulation A, Tier 2 public offering for unaccredited and accredited investors. Now anyone can become a shareholder in Item 9 Labs Corp., which includes the national dispensary franchise, Unity Rd. and premium, award-winning cannabis brand Item 9 Labs. The Company is offering 28 million Units Each Comprised of One Share and One-Half of One Warrant. Upon the exercise of all warrants, the offering has maximum proceeds of $67.2 million.

 

Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis franchisor and operator headquartered in Arizona that produces premium, award-winning products. With deep experience in cannabis, franchising, and capital markets, the Company brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. (PRNewsfoto/Item 9 Labs Corp.)

With new states continuing to legalize cannabis, the industry is on track to explode – projecting $45 billion in revenue by 2025, a 50 percent increase from 2021*. As large players increasingly dominate the space, the business landscape will become even more challenging for new and independent entrepreneurs. The complexities of operating a cannabis business make it difficult for small, independent dispensaries to understand and stay on top of all the varying regulations and everyday challenges of managing and operating a compliant and successful dispensary.

 

The Company’s offering is set to accelerate the solution. Promoted under its “Keep Cannabis Local” campaign, this funding round offers the opportunity to invest in cannabis entrepreneurship, keeping the door to cannabis ownership open to industry newcomers and existing operators alike.

 

“Dispensary ownership is a lucrative opportunity, but it comes with a considerable amount of challenges to navigate,” said Item 9 Labs Corp.’s CEO Andrew Bowden. “The combination of our brands are the solution.”

 

Unity Rd. shops are rolling out state-by-state, community-by-community, and keeping dispensary ownership in the hands of local entrepreneurs nationwide. The franchise opportunity provides a viable opportunity for industry newcomers and small, locally owned and operated dispensaries to compliantly thrive, thanks to the robust backing and support of a national franchise. Unity Rd. offers direct access to the buying power, resources and supportive network normally reserved for multi-unit cannabis operators – empowering local, independents to confidently run their business.

 

“Unity Rd. offers one of the safest ways to enter the complex cannabis space with an experienced team guiding the path forward and supporting across all functions of the business,” Bowden added. “Franchising will propel the cannabis industry and keep business ownership in the hands of local owners.”

 

As the Unity Rd. franchise network expands nationally, the Company plans to bring Item 9 Labs products to the market through corporate development, acquisitions or partnerships with cultivation facilities in states where Unity Rd. franchise partners open cannabis retail shops. This strategic growth plan gives Unity Rd. operators front-of-the-line access to a reliable, award- winning product supply chain and offers the national product consistency that consumers have come to expect from franchises. This strategy also eases new market entry for Item 9 Labs products and creates unmatched market power across borders.

 

The Company encourages all interested investors to visit keepcannabislocal.com for a link to the Offering Circular and to learn how to invest in the offering. For more information on Item 9 Labs Corp. and its brands, visit item9labscorp.comView the offering circular directly by clicking here.

 

For information about the Unity Rd. franchise opportunity, contact franchise@unityrd.com, call 720-923-5262 or visit unityrd.com.

 

About Item 9 Labs Corp.
Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 640,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit item9labscorp.com.

 

About Unity Rd.
Unity Rd. is bridging the two previously disconnected worlds of cannabis and franchising. The industry trailblazer is the first to bring the cannabis dispensary franchise model to the United States—with duality of prowess in both industries to back it up. Built up from a collective 200 years in the legal cannabis industry and franchising, the company helps eager operators enter the complex industry with ease. The marijuana franchise pioneer offers its partners the knowledge, resources, and ongoing support needed to compliantly and successfully operate a dispensary. Launched in 2018, Unity Rd. has signed multiple agreements with nearly 20 entrepreneurial groups across the country. Recently, it was named one of the top cannabis retail leaders in the nation by MJBizDaily magazine and one of the “Best Cannabis Companies to Work For” in both the dispensary and cultivation categories in Cannabis Business Times’ elite 2020 list. The company is also the first cannabis business to earn a Franchise Times Dealmakers award. For more information, visit unityrd.com.

 

Forward-Looking Statement:
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, proposed transactions that are not legally binding obligations of the company and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

https://mjbizdaily.com/new-marijuana-business-factbook-projects-nearly-45-billion-us-market- by-2025/

 

Media Contact:
Item 9 Labs Corp.
Jayne Levy, VP of Communications
Email: Jayne@item9labs.com

 

Investor Contact:
Item 9 Labs Corp.
Phone: 800-403-1140
Email: investors@item9labscorp.com

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading